Literature DB >> 12531889

Binding of filamin to the C-terminal tail of the calcitonin receptor controls recycling.

Thomas Seck1, Roland Baron, William C Horne.   

Abstract

Many G protein-coupled receptors undergo endocytosis, but the mechanisms involved in endocytic sorting and recycling remain to be fully elucidated. We found that the G protein-coupled calcitonin receptor (CTR) undergoes tonic internalization and accumulates within the cell. Using a fluorescence loss in photobleaching assay, we classified these vesicles functionally as recycling vesicles. In a two-hybrid screening, we found that the actin-binding protein filamin interacted with the C-terminal tail of the CTR. The degradation of the receptor was profoundly increased in the absence of filamin or the CTR-filamin interaction. The absence of filamin was also associated with a marked decrease in recycling of the receptor from the endosomes to the cell surface. In contrast, calcitonin-induced inhibition of spontaneous filamin proteolysis was associated with increased recycling of the receptor to the cell surface and decreased degradation of the CTR, suggesting an important role for filamin in the endocytic sorting and recycling of the internalized CTR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531889     DOI: 10.1074/jbc.M209655200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Identification and Characterization of a Synthetic Osteogenic Peptide.

Authors:  David E Komatsu; Michael Hadjiargyrou; Sardar M Z Udin; Nicholas A Trasolini; Srinivas Pentyala
Journal:  Calcif Tissue Int       Date:  2015-08-29       Impact factor: 4.333

2.  The cytoplasmic domain of neuropilin-1 regulates focal adhesion turnover.

Authors:  Himabindu Reddy Seerapu; Susmita Borthakur; Nathan Kong; Sudesh Agrawal; Judy Drazba; Amit Vasanji; Alessandro Fantin; Christiana Ruhrberg; Matthias Buck; Arie Horowitz
Journal:  FEBS Lett       Date:  2013-09-08       Impact factor: 4.124

3.  The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling.

Authors:  Thomas Seck; Maria Pellegrini; Ana Maria Florea; Veronique Grignoux; Roland Baron; Dale F Mierke; William C Horne
Journal:  Mol Endocrinol       Date:  2005-04-28

Review 4.  Regulation of G protein-coupled receptor export trafficking.

Authors:  Chunmin Dong; Catalin M Filipeanu; Matthew T Duvernay; Guangyu Wu
Journal:  Biochim Biophys Acta       Date:  2006-09-23

5.  Molecular mechanics of filamin's rod domain.

Authors:  Kevin S Kolahi; Mohammad R K Mofrad
Journal:  Biophys J       Date:  2007-10-05       Impact factor: 4.033

6.  Obligatory roles of filamin A in E-cadherin-mediated cell-cell adhesion in epidermal keratinocytes.

Authors:  Chia-Ling Tu; Michael You
Journal:  J Dermatol Sci       Date:  2013-09-26       Impact factor: 4.563

7.  Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility.

Authors:  Leah Rider; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2011-05-12

8.  Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.

Authors:  Anne-Sophie Wattiez; Levi P Sowers; Andrew F Russo
Journal:  Expert Opin Ther Targets       Date:  2020-02-13       Impact factor: 6.902

Review 9.  Filamin structure, function and mechanics: are altered filamin-mediated force responses associated with human disease?

Authors:  Andrew J Sutherland-Smith
Journal:  Biophys Rev       Date:  2011-01-27

10.  Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells.

Authors:  Jennifer L Fiori; Tie-Nian Zhu; Michael P O'Connell; Keith S Hoek; Fred E Indig; Brittany P Frank; Christa Morris; Sutapa Kole; Joanne Hasskamp; George Elias; Ashani T Weeraratna; Michel Bernier
Journal:  Endocrinology       Date:  2009-02-12       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.